A new trading day began on Monday, with Axsome Therapeutics Inc (NASDAQ: AXSM) stock price up 3.07% from the previous day of trading, before settling in for the closing price of $108.98. AXSM’s price has ranged from $72.21 to $139.13 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -24.44% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 44.18%. With a float of $40.45 million, this company’s outstanding shares have now reached $49.22 million.
In an organization with 683 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 91.49%, operating margin of -62.54%, and the pretax margin is -64.37%.
Axsome Therapeutics Inc (AXSM) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Axsome Therapeutics Inc is 17.84%, while institutional ownership is 74.84%. The most recent insider transaction that took place on Jun 20 ’25, was worth 768,525. In this transaction General Counsel of this company sold 7,500 shares at a rate of $102.47, taking the stock ownership to the 0 shares. Before that another transaction happened on Jun 23 ’25, when Company’s General Counsel sold 6,014 for $100.12, making the entire transaction worth $602,122. This insider now owns 0 shares in total.
Axsome Therapeutics Inc (AXSM) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 44.18% per share during the next fiscal year.
Axsome Therapeutics Inc (NASDAQ: AXSM) Trading Performance Indicators
Here are Axsome Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.96. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 12.80.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.77, a number that is poised to hit -1.05 in the next quarter and is forecasted to reach 1.57 in one year’s time.
Technical Analysis of Axsome Therapeutics Inc (AXSM)
Let’s dig in a bit further. During the last 5-days, its volume was 0.76 million. That was inferior than the volume of 0.81 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 67.88%.
During the past 100 days, Axsome Therapeutics Inc’s (AXSM) raw stochastic average was set at 48.60%, which indicates a significant decrease from 83.57% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 3.50 in the past 14 days, which was lower than the 4.10 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $106.99, while its 200-day Moving Average is $103.54. However, in the short run, Axsome Therapeutics Inc’s stock first resistance to watch stands at $114.13. Second resistance stands at $115.93. The third major resistance level sits at $118.53. If the price goes on to break the first support level at $109.73, it is likely to go to the next support level at $107.13. Assuming the price breaks the second support level, the third support level stands at $105.33.
Axsome Therapeutics Inc (NASDAQ: AXSM) Key Stats
With a market capitalization of 5.53 billion, the company has a total of 49,236K Shares Outstanding. Currently, annual sales are 385,690 K while annual income is -287,220 K. The company’s previous quarter sales were 121,460 K while its latest quarter income was -59,410 K.
